Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCL4L1 antibody (Internal Region)

The Rabbit Polyclonal anti-CCL4L1 antibody has been validated for WB and ELISA. It is suitable to detect CCL4L1 in samples from Human.
Catalog No. ABIN7187300

Quick Overview for CCL4L1 antibody (Internal Region) (ABIN7187300)

Target

See all CCL4L1 Antibodies
CCL4L1 (Chemokine (C-C Motif) Ligand 4-Like 1 (CCL4L1))

Reactivity

Human

Host

  • 4
  • 1
Rabbit

Clonality

  • 4
  • 1
Polyclonal

Conjugate

  • 5
This CCL4L1 antibody is un-conjugated

Application

  • 5
  • 4
  • 3
  • 3
  • 2
Western Blotting (WB), ELISA
  • Binding Specificity

    • 3
    • 1
    Internal Region

    Cross-Reactivity

    Human

    Purification

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    Synthesized peptide derived from the Internal region of Human MIP-1b.

    Isotype

    IgG
  • Application Notes

    WB:1:500-1:2000, ELISA:1:10000,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    CCL4L1 (Chemokine (C-C Motif) Ligand 4-Like 1 (CCL4L1))

    Alternative Name

    CCL4L1

    Background

    CCL4L1 antibody, CCL4L antibody, LAG1 antibody, SCYA4L1, antibody, CCL4L2 antibody, CCL4L antibody, SCYA4L2C-C motif chemokine 4-like antibody, Lymphocyte activation gene 1 protein antibody, LAG-1 antibody, Macrophage inflammatory protein 1-beta antibody, MIP-1-beta antibody, Monocyte adherence-induced protein 5-alpha antibody, Small-inducible cytokine A4-like antibody

    UniProt

    Q8NHW4
You are here:
Chat with us!